China’s oral GLP-1 weight-loss pills advance as seven candidates race to market
Yipinhong’s APH04935 wins FDA clinical clearance, as two Chinese-developed oral small-molecule GLP-1 drugs reach the marketing…
Early Shanghai trial data points to promise for therapeutic mRNA cancer vaccines
By Da Cheung The American Society of Clinical Oncology (ASCO) annual meeting, which concluded on June…
Latest
- China’s oral GLP-1 weight-loss pills advance as seven candidates race to market
- Zhang Yiming’s AI drug discovery spin-off hits $1.5 billion valuation
- Mecka AI raises $60 million as Sequoia and Nvidia bet on robot training data
- Doubao’s AI phone rejected by major platforms
- Infinigence secures 2.3 billion yuan in fresh funds
